Ongoing XMRV research projects funded by the NIH

[Bob]

I'm not sure if this information has been posted anywhere on the forum before.
I haven't read through it all carefully yet, but it looks like there might be some interesting XMRV projects here.

Dr Jamie Deckoff-Jones posted the links on her blog...
The Fire Smolders
Tuesday, June 7, 2011
http://treatingxmrv.blogspot.com/2011/06/here-are-more-abstracts-about-xmrv-from.html

Research Projects funded by the NIH

Molecular Basis For The Pathogenesis Of Murine Retroviruses
Ruscetti, Sandra K
Division Of Basic Sciences - NCI
http://projectreporter.nih.gov/project_info_description.cfm?aid=8157190&icde=8392424

Genetic Aspects Of Viral Oncogenesis In Wild Mouse Species
Kozak, Christine
National Institute Of Allergy And Infectious Diseases
http://projectreporter.nih.gov/project_info_description.cfm?aid=8156820&icde=8392424

Inflammation And Prostate Carcinogenesis
Hurwitz, Arthur
Division Of Basic Sciences - NCI
http://projectreporter.nih.gov/project_info_description.cfm?aid=8157670&icde=8392424

Detection And Analysis Of Mouse Retroviruses In Humans
Maldarelli, Frank
Division Of Basic Sciences - NCI
http://projectreporter.nih.gov/project_info_description.cfm?aid=8157762&icde=8392424

Viral And Cellular Factors Governing Efficient Gene Delivery
Eiden, Maribeth V.
National Institute Of Mental Health
http://projectreporter.nih.gov/project_info_description.cfm?aid=8158079&icde=8392424

The Role Of XMRV, A Newly Discovered Human Retrovirus, In Cancer Pathogenesi
Singh, Ila R
University Of Utah
http://projectreporter.nih.gov/project_info_description.cfm?aid=8040941&icde=8392424

 

[markmc20001]

Hey Bob,

FYI: National cancer institute has research facilities at Fort Detrick.

http://ww2.gazette.net/stories/06022011/busiflo170635_32533.php

Science Applications International Corp. of McLean, Va., has tapped a pharmaceutical industry veteran to lead SAIC-Frederick, its wholly owned subsidiary that supports the National Cancer Institute's operations at Fort Detrick.

David Heimbrook, with more than 20 years of experience with Hoffman-LaRoche, Merck Research Laboratories and Smith Kline & French Laboratories, has been named CEO, succeeding Larry O. Arthur.

Arthur, CEO since 2000, will remain as chief scientist, company officials said in a statement. Heimbrook could not be reached for comment.

The roughly 2,000 employees at SAIC-Frederick provide operations and technical support to the cancer institute's research and development center at Fort Detrick under a 10-year contract awarded in 2008 to develop new technologies to prevent, diagnose and treat cancer and AIDS, officials said

Fort Detrick was set up By the CEO of Merck back during World War 2

http://www.detrick.army.mil/cutting_edge/chapter04.cfm

The scientific era of Fort Detrick began in 1943. Gone were the aircraft from Detrick Field. In their stead came men new to uniforms, but skilled in their craft. Their purpose in March 1943 was twofold: in broad terms, they were to develop defensive mechanisms against biological attack; and they were to develop weapons, with which the United States could respond "in kind" if attacked by an enemy, which deployed biological weapons.

This was an enormous task [wrote Lieutenant Colonel Richard M. Clendenin in his booklet SCIENCE and TECHNOLOGY at Fort Detrick, 1943-1968] . . . it was literally without precedent and had to be prosecuted with all possible haste.

The mounting threat of the German "buzz bombs" that were raining on England from launching sites on the Continent during 1943 spurred the urgency of BW (biological warfare) defense because it was thought that these high-explosive rockets might easily be converted into efficient weapons for massive BW attacks.

From the moment of its birth in the highest levels of government, the fledgling biological warfare effort was kept to an inner circle of knowledgeable persons. George W. Merck was a key member of the panel advising President Franklin D. Roosevelt and was charged with putting such an effort together. Merck owned the pharmaceutical firm that still bears his name.

Merck brought into uniform men and women with skills in several scientific disciplines. Among them was Dr. Ira L. Baldwin, professor of bacteriology at the University of Wisconsin. He became the first scientific director.

The Army Chemical Warfare Service was given responsibility and oversight for the effort that Clendenin wrote was "cloaked in the deepest wartime secrecy, matched only by . . . the Manhattan Project for developing the Atomic Bomb."

Fort Detrick also did vaccine research:

25 November 1969: During a visit to Fort Detrick, President Nixon renounces the development, production, stockpiling, and use of biological warfare agents. He also reaffirms the US no-first-use policy for chemical weapons and agrees to submit the Geneva Protocol to the Senate for consideration. Toxins are added to the biological weapons ban on 14 February 1970. The Department of Defense is required to dispose of existing biological weapons and scale down the program to include research only for defensive measures. In the wake of the announcement, the US Army Medical Unit changes its name to the US Army Medical Research Institute of Infectious Diseases (USAMRIID). The focus of USAMRIID shifts to the development of vaccines, protective measures, and detection systems.

Then after the violations to humans at Ft. Detrick, MD, and on November 25, 1969, Then President Richard Nixon, through then Secretary of State, Henry Kissinger, The National Security Council Memorandum Number 35 ordered the Biological Warfare Center to be closed.

Reference #3 Declassified National Security Council Document from November 25, 1969, National Security Memorandum 35 - See pages 1, 2, and 3

http://www.sabotagedatftdetrick.com/

DR Burzynski (see burzynski movie, and accompanying references on his website Burzynskimoive.com) documents the NCI trying to modify his cancer treatment protocol during trials.